These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 28361470)

  • 1. Pathogenesis of calcium oxalate urinary stone disease: species comparison of humans, dogs, and cats.
    O'Kell AL; Grant DC; Khan SR
    Urolithiasis; 2017 Aug; 45(4):329-336. PubMed ID: 28361470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helper T-cell signaling and inflammatory pathway lead to formation of calcium phosphate but not calcium oxalate stones on Randall's plaques.
    Taguchi K; Hamamoto S; Okada A; Sugino T; Unno R; Ando R; Gao B; Tozawa K; Kohri K; Yasui T
    Int J Urol; 2019 Jun; 26(6):670-677. PubMed ID: 30919502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the papilla in idiopathic calcium oxalate nephrolithiasis.
    Krautschick A; Esen T
    World J Urol; 1997; 15(4):213-8. PubMed ID: 9280049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel porcine model for calcium oxalate stone formation.
    Trojan BP; Trojan SJ; Navetta A; Staches B; Sutton B; Filleur S; Nelius T
    Int Urol Nephrol; 2017 Oct; 49(10):1751-1761. PubMed ID: 28707190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic and urinary risk factors associated with Randall's papillary plaques.
    Low RK; Stoller ML; Schreiber CK
    J Endourol; 2000 Aug; 14(6):507-10. PubMed ID: 10954308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic mapping of renal papillae for Randall's plaques in patients with urinary stone disease.
    Low RK; Stoller ML
    J Urol; 1997 Dec; 158(6):2062-4. PubMed ID: 9366312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomimetic Randall's plaque as an in vitro model system for studying the role of acidic biopolymers in idiopathic stone formation.
    Chidambaram A; Rodriguez D; Khan S; Gower L
    Urolithiasis; 2015 Jan; 43 Suppl 1(0 1):77-92. PubMed ID: 25119505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role of fluctuations in the composition of renal tubular fluid through the nephron in the initiation of Randall's plugs and calcium oxalate crystalluria in a computer model of renal function.
    Robertson WG
    Urolithiasis; 2015 Jan; 43 Suppl 1():93-107. PubMed ID: 25407799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiopathic calcium nephrolithiasis: a review of pathogenic mechanisms in the light of genetic studies.
    Arcidiacono T; Mingione A; Macrina L; Pivari F; Soldati L; Vezzoli G
    Am J Nephrol; 2014; 40(6):499-506. PubMed ID: 25504362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactive oxygen species as the molecular modulators of calcium oxalate kidney stone formation: evidence from clinical and experimental investigations.
    Khan SR
    J Urol; 2013 Mar; 189(3):803-11. PubMed ID: 23022011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current concepts on the pathogenesis of urinary stones].
    Mager R; Neisius A
    Urologe A; 2019 Nov; 58(11):1272-1280. PubMed ID: 31432240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of liver X receptor suppresses osteopontin expression and ameliorates nephrolithiasis.
    Chen J; Zhang D; Ji MF; Liu T; Mei CL; Tang XJ
    J Cell Physiol; 2019 Aug; 234(8):14109-14122. PubMed ID: 30623435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randall's plaque: pathogenesis and role in calcium oxalate nephrolithiasis.
    Evan A; Lingeman J; Coe FL; Worcester E
    Kidney Int; 2006 Apr; 69(8):1313-8. PubMed ID: 16614720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro evaluation of canine and feline calcium oxalate urolith fragility via shock wave lithotripsy.
    Adams LG; Williams JC; McAteer JA; Hatt EK; Lingeman JE; Osborne CA
    Am J Vet Res; 2005 Sep; 66(9):1651-4. PubMed ID: 16261842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-Wide Gene Expression Profiling of Randall's Plaques in Calcium Oxalate Stone Formers.
    Taguchi K; Hamamoto S; Okada A; Unno R; Kamisawa H; Naiki T; Ando R; Mizuno K; Kawai N; Tozawa K; Kohri K; Yasui T
    J Am Soc Nephrol; 2017 Jan; 28(1):333-347. PubMed ID: 27297950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update: Management of calcium oxalate uroliths in dogs and cats.
    Bartges JW; Kirk C; Lane IF
    Vet Clin North Am Small Anim Pract; 2004 Jul; 34(4):969-87, vii. PubMed ID: 15223211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxalate-Degrading Bacillus subtilis Mitigates Urolithiasis in a Drosophila melanogaster Model.
    Al KF; Daisley BA; Chanyi RM; Bjazevic J; Razvi H; Reid G; Burton JP
    mSphere; 2020 Sep; 5(5):. PubMed ID: 32907948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randall's plaque and calcium oxalate stone formation: role for immunity and inflammation.
    Khan SR; Canales BK; Dominguez-Gutierrez PR
    Nat Rev Nephrol; 2021 Jun; 17(6):417-433. PubMed ID: 33514941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal papillary attenuation differences between primary and recurrent idiopathic calcium stone disease patients.
    Cakiroglu B; Eyyupoglu SE; Tas T; Esen T; Acar O; Aksoy SH
    Minerva Urol Nefrol; 2014 Jun; 66(2):107-12. PubMed ID: 24988201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.